DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 148 filers reported holding DENALI THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.39 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $36,515 | -95.2% | 1,313 | -94.7% | 0.00% | -100.0% |
| Q3 2022 | $767,000 | +33.6% | 25,000 | +94.2% | 0.00% | 0.0% |
| Q4 2021 | $574,000 | +78.8% | 12,874 | +102.3% | 0.00% | +100.0% |
| Q3 2021 | $321,000 | -96.0% | 6,364 | -93.8% | 0.00% | -97.4% |
| Q2 2021 | $7,996,000 | +105.6% | 101,934 | +49.7% | 0.04% | +100.0% |
| Q1 2021 | $3,889,000 | -7.3% | 68,102 | +36.0% | 0.02% | -17.4% |
| Q4 2020 | $4,194,000 | +83.0% | 50,074 | -21.7% | 0.02% | +35.3% |
| Q3 2020 | $2,292,000 | +141.3% | 63,960 | +17.9% | 0.02% | +54.5% |
| Q1 2020 | $950,000 | -62.0% | 54,266 | -54.9% | 0.01% | -31.2% |
| Q2 2019 | $2,500,000 | – | 120,402 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 7,460,732 | $219,569,000 | 28.65% |
| ARCH Venture Management, LLC | 5,168,749 | $152,116,000 | 18.54% |
| Casdin Capital, LLC | 1,500,000 | $44,145,000 | 3.73% |
| Flagship Pioneering Inc. | 2,619,968 | $77,106,000 | 2.90% |
| Yiheng Capital Management, L.P. | 1,014,684 | $29,862,000 | 1.71% |
| SECTORAL ASSET MANAGEMENT INC | 202,100 | $5,948,000 | 1.20% |
| GILDER GAGNON HOWE & CO LLC | 1,956,820 | $57,589,000 | 1.03% |
| Artal Group S.A. | 600,000 | $17,658,000 | 0.94% |
| Temasek Holdings (Private) Ltd | 5,369,487 | $158,024,002 | 0.87% |
| BRANDYWINE MANAGERS, LLC | 9,601 | $283,000 | 0.69% |